Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8441210 | European Journal of Cancer | 2016 | 10 Pages |
Abstract
: Isolated AR is more common in Her2-positive/HR-negative triple-negative tumours with a more severe prognosis in triple-negative and Her2-positive/HR-negative tumours, and represents an independent adverse factor justifying an indication for systemic treatment for AR treatment. However, the benefit of any systemic treatment remains to be proven.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Gilles Houvenaeghel, Jean Marc Classe, Jean-Rémy Garbay, Sylvie Giard, Monique Cohen, Chistine Faure, Hélène Charytansky, Roman Rouzier, Emile Daraï, Delphine Hudry, Pierre Azuar, Richard Villet, Pierre Gimbergues, Christine Tunon de Lara,